Drug Discovery:

Drug Target Validation

Prioritize and identify genetic variants as potential drug targets using our VERG platform. 

 

Ranomics' streamlined enables the characterization of thousands of genetic variants at once using a diverse set of biological readouts including: 

​

• cellular growth

• post-translational modifications

• synthetic reporters 

 

Our analyses can be conducted across multiple cell lines to assess whether any genetic variant contributes to disease etiology and can serve as an effective therapeutic target. 

​

Accelerate cell-based studies with Ranomics and identify high-quality drug targets faster.